Citations (52)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Yuwei Ding, Juan Wang, Ning Zhu, Dong Xu, Kefeng Ding & Ying Yuan. (2020) Fruquintinib effectively controlled the advanced small bowel adenocarcinoma progressed after multiple lines of palliative treatment: a case report and literature review. Cancer Biology & Therapy 21:12, pages 1105-1108.
Read now
Read now
Maryam Balibegloo & Nima Rezaei. (2020) Development and clinical application of bispecific antibody in the treatment of colorectal cancer. Expert Review of Clinical Immunology 16:7, pages 689-709.
Read now
Read now
Hanan H. Sabry, Neveen E. Sorour & Essam M. Akl. (2020) Intralesional injection of bevacizumab versus triamcinolone acetonide in infantile hemangioma. Journal of Dermatological Treatment 31:3, pages 279-284.
Read now
Read now
Ying Zhang, Jia-Yun Zou, Zhe Wang & Ying Wang. (2019) Fruquintinib: a novel antivascular endothelial growth factor receptor tyrosine kinase inhibitor for the treatment of metastatic colorectal cancer. Cancer Management and Research 11, pages 7787-7803.
Read now
Read now
Zhongguang Chen & Lili Jiang. (2019) The clinical application of fruquintinib on colorectal cancer. Expert Review of Clinical Pharmacology 12:8, pages 713-721.
Read now
Read now
Jing Zhang, Beili Gao, Wenchao Zhang, Zijun Qian & Yi Xiang. (2018) Monitoring antiangiogenesis of bevacizumab in zebrafish. Drug Design, Development and Therapy 12, pages 2423-2430.
Read now
Read now
Mariona Cabo, Rienk Offringa, Laurence Zitvogel, Guido Kroemer, Aura Muntasell & Lorenzo Galluzzi. (2017) Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications. OncoImmunology 6:12.
Read now
Read now
Articles from other publishers (45)
Huijiao Jiang, Xiaoyi Wang, Lijiao Guo, Xiaowu Tan, Xianwei Gui, Zhenyu Liao, Zhiwei Li, Xueling Chen & Xiangwei Wu. (2023) Effect of sunitinib against Echinococcus multilocularis through inhibition of VEGFA-induced angiogenesis. Parasites & Vectors 16:1.
Crossref
Crossref
Arvind Dasari, Sara Lonardi, Rocio Garcia-Carbonero, Elena Elez, Takayuki Yoshino, Alberto Sobrero, James Yao, Pilar García-Alfonso, Judit Kocsis, Antonio Cubillo Gracian, Andrea Sartore-Bianchi, Taroh Satoh, Violaine Randrian, Jiri Tomasek, Geoff Chong, Andrew Scott Paulson, Toshiki Masuishi, Jeremy Jones, Tibor Csőszi, Chiara Cremolini, Francois Ghiringhelli, Ardaman Shergill, Howard S Hochster, John Krauss, Ali Bassam, Michel Ducreux, Anneli Elme, Laurence Faugeras, Stefan Kasper, Eric Van Cutsem, Dirk Arnold, Shivani Nanda, Zhao Yang, William R Schelman, Marek Kania, Josep Tabernero & Cathy Eng. (2023) Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study. The Lancet 402:10395, pages 41-53.
Crossref
Crossref
Man You, Junmin Fu, Xingzhi Lv, Lan Wang, Hongwei Wang & Ruifang Li. (2023) Saikosaponin b2 inhibits tumor angiogenesis in liver cancer via down‑regulation of VEGF/ERK/HIF‑1α signaling. Oncology Reports 50:1.
Crossref
Crossref
Fan-Jie Qu, Shuang Wu & Yan Kong. (2023) Oral fruquintinib combined with tegafur-gimeracil-oteracil potassium for advanced colorectal cancer to obtain longer progression-free survival: A case report. World Journal of Gastrointestinal Oncology 15:5, pages 902-909.
Crossref
Crossref
Ioana Mihaela Dinu, Mariana Mihăilă, Mircea Mihai Diculescu, Vlad Mihai Croitoru, Adina Turcu-Stiolica, Diana Bogdan, Monica Ionela Miron, Cristian Virgil Lungulescu, Sorin Tiberiu Alexandrescu, Traian Dumitrașcu, Florina Buică, Ioana Niculina Luca, Cristina Lungulescu, Madalina Cristina Negulescu, Iulia Magdalena Gramaticu, Irina Mihaela Cazacu & Adina Emilia Croitoru. (2023) Bevacizumab Treatment for Metastatic Colorectal Cancer in Real-World Clinical Practice. Medicina 59:2, pages 350.
Crossref
Crossref
Khanh B. Tran, Sharada Kolekar, Qian Wang, Jen-Hsing Shih, Christina M. Buchanan, Sanjeev Deva & Peter R. Shepherd. (2022) Response to BRAF-targeted Therapy Is Enhanced by Cotargeting VEGFRs or WNT/β-Catenin Signaling in BRAF-mutant Colorectal Cancer Models. Molecular Cancer Therapeutics 21:12, pages 1777-1787.
Crossref
Crossref
Aujala Irfan Khan, Ghadi D Mashat, Mohammad Hazique, Kokab Irfan Khan, Prasana Ramesh, Suthasenthuran Kanagalingam, FNU Zargham Ul Haq, Nishok Victory Srinivasan & Safeera Khan. (2022) Efficacy and Safety of Apatinib in the Treatment of Chemotherapy-Refractory Metastatic Colorectal Cancer: A Systematic Review. Cureus.
Crossref
Crossref
Tianshu Ren, Hui Jia, Qiong Wu, Yan Zhang, Qun Ma, Dong Yao, Xudong Gao, Danni Xie, Zihua Xu, Qingchun Zhao & Yingshi Zhang. (2022) Inhibition of Angiogenesis and Extracellular Matrix Remodeling: Synergistic Effect of Renin-Angiotensin System Inhibitors and Bevacizumab. Frontiers in Oncology 12.
Crossref
Crossref
Heejin Bang, Ja Eun Kim, Hyun Su Lee, Sang Man Park, Dong-Joon Park & Eun Jung Lee. (2022) Integrated bioinformatic analysis of gene expression profiling data to identify combinatorial biomarkers in inflammatory skin disease. Scientific Reports 12:1.
Crossref
Crossref
Sophie Bekisz, Louis Baudin, Florence Buntinx, Agnès Noël & Liesbet Geris. (2022) In Vitro, In Vivo, and In Silico Models of Lymphangiogenesis in Solid Malignancies. Cancers 14:6, pages 1525.
Crossref
Crossref
Chuqi Wang & Ming Chu. (2022) Advances in Drugs Targeting Lymphangiogenesis for Preventing Tumor Progression and Metastasis. Frontiers in Oncology 11.
Crossref
Crossref
Tobiloba C. Elebiyo, Damilare Rotimi, Ikponmwosa O. Evbuomwan, Rotdelmwa Filibus Maimako, Matthew Iyobhebhe, Oluwafemi Adeleke Ojo, Olarewaju M. Oluba & Oluyomi S. Adeyemi. (2022) Reassessing vascular endothelial growth factor (VEGF) in anti-angiogenic cancer therapy. Cancer Treatment and Research Communications 32, pages 100620.
Crossref
Crossref
Maohua Huang, Mingqun Liu, Dandan Huang, Yanping Ma, Geni Ye, Qing Wen, Yong Li, Lijuan Deng, Qi Qi, Tongzheng Liu, Xiangning Liu, Minfeng Chen, Wencai Ye & Dongmei Zhang. (2022) Tumor perivascular cell-derived extracellular vesicles promote angiogenesis via the Gas6/Axl pathway. Cancer Letters 524, pages 131-143.
Crossref
Crossref
Carolina Nunes da Silva, Lays Fernanda Nunes Dourado, Luciana Maria Silva, Aline Brito de Lima, Maria Elena de Lima, Armando Silva-Cunha & Silvia Ligório Fialho. (2022) Pathophysiological Effects of Lycosa erythrognatha Derived Peptide LyeTxI-b on RKO-AS-45-1 Colorectal Carcinoma Cell Line Using the Chicken Chorioallantoic Membrane Model. International Journal of Peptide Research and Therapeutics 28:1.
Crossref
Crossref
Li Chen, Man He, Meng Zhang, Qiang Sun, Sha Zeng, Hui Zhao, Han Yang, Maolun Liu, Shan Ren, Xianli Meng & Haibo Xu. (2021) The Role of non-coding RNAs in colorectal cancer, with a focus on its autophagy. Pharmacology & Therapeutics 226, pages 107868.
Crossref
Crossref
Ning Li, Wenying Deng, Guifang Zhang, Yali Du, Yanwei Guo, Yijie Ma, Chen Wei, Liangyu Bie, Chi Zhang, Tao Song, Suxia Luo & Baijun Fang. (2021) Low-Dose Apatinib Combined With S-1 in Refractory Metastatic Colorectal Cancer: A Phase 2, Multicenter, Single-Arm, Prospective Study. Frontiers in Oncology 11.
Crossref
Crossref
Arvind Dasari, Alberto Sobrero, James Yao, Takayuki Yoshino, William Schelman, Zhao Yang, Caly Chien, Marek Kania, Josep Tabernero & Cathy Eng. (2021) FRESCO-2: a global Phase III study investigating the efficacy and safety of fruquintinib in metastatic colorectal cancer. Future Oncology 17:24, pages 3151-3162.
Crossref
Crossref
Yeong Hak Bang, Yong Sang Hong, Ji Sung Lee, Keun-Wook Lee, Hye Sook Han, Sun Young Kim, Ji-Won Kim, Hee Kyung Kim, Jin Won Kim, Choi Ki Eun, Tae Won Kim & Jeong Eun Kim. (2021) Effectiveness of Combining Bevacizumab With First-Line Chemotherapy Regimens for Metastatic Colorectal Cancer in Real-World Practice. Clinical Colorectal Cancer 20:2, pages 101-112.e6.
Crossref
Crossref
Jin Hwang, Hye-Won Yang, Yu An Lu, Jun-Geon Je, Hyo-Geun Lee, K.H.N. Fernando, You-Jin Jeon & BoMi Ryu. (2021) Phloroglucinol and dieckol isolated from Ecklonia cava suppress impaired diabetic angiogenesis; A study of in-vitro and in-vivo. Biomedicine & Pharmacotherapy 138, pages 111431.
Crossref
Crossref
Digna Parmar & Madhavi Apte. (2021) Angiopoietin inhibitors: A review on targeting tumor angiogenesis. European Journal of Pharmacology 899, pages 174021.
Crossref
Crossref
Maohua Huang, Minfeng Chen, Ming Qi, Geni Ye, Jinghua Pan, Changzheng Shi, Yunlong Yang, Luyu Zhao, Xukai Mo, Yiran Zhang, Yong Li, Jincheng Zhong, Weijin Lu, Xiaobo Li, Jiayan Zhang, Jinrong Lin, Liangping Luo, Tongzheng Liu, Patrick Ming‐Kuen Tang, An Hong, Yihai Cao, Wencai Ye & Dongmei Zhang. (2021) Perivascular cell‐derived extracellular vesicles stimulate colorectal cancer revascularization after withdrawal of antiangiogenic drugs. Journal of Extracellular Vesicles 10:7.
Crossref
Crossref
Ruihua Xu, Shukui Qin, Weijian Guo, Yuxian Bai, Yanhong Deng, Lei Yang, Zhendong Chen, Haijun Zhong, Hongming Pan, Yongqian Shu, Ying Yuan, Jianfeng Zhou, Nong Xu, Tianshu Liu, Dong Ma, Changping Wu, Ying Cheng, Jianming Xu, Donghui Chen, Wei Li, Sanyuan Sun, Zhuang Yu, Peiguo Cao, Jian Li, Haihui Chen, Jiejun Wang, Shubin Wang, Hongbing Wang, Ning Wang, Bin Zhang, Rubing Han, Weiguo Su, Xiaojun Guo & Jin Li. (2021) Subgroup analysis by prior anti-VEGFor anti-EGFR target therapy in FRESCO,a randomized, double-blind, Phase III trial. Future Oncology 17:11, pages 1339-1350.
Crossref
Crossref
Alessandro Ottaiano, Stefania Scala, Mariachiara Santorsola, Anna Maria Trotta, Crescenzo D’Alterio, Luigi Portella, Ottavia Clemente, Anna Nappi, Nicoletta Zanaletti, Alfonso De Stefano, Antonio Avallone, Vincenza Granata, Carmen Notariello, Amalia Luce, Angela Lombardi, Carmine Picone, Antonella Petrillo, Francesco Perri, Fabiana Tatangelo, Annabella Di Mauro, Vittorio Albino, Francesco Izzo, Daniela Rega, Ugo Pace, Massimiliano Di Marzo, Paolo Chiodini, Gianfranco De Feo, Paola Del Prete, Gerardo Botti, Paolo Delrio, Michele Caraglia & Guglielmo Nasti. (2021) Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol. Therapeutic Advances in Medical Oncology 13, pages 175883592198922.
Crossref
Crossref
Jack Martin, Angelica Petrillo, Elizabeth C Smyth, Nadeem Shaida, Samir Khwaja, HK Cheow, Adam Duckworth, Paula Heister, Raaj Praseedom, Asif Jah, Anita Balakrishnan, Simon Harper, Siong Liau, Vasilis Kosmoliaptsis & Emmanuel Huguet. (2020) Colorectal liver metastases: Current management and future perspectives. World Journal of Clinical Oncology 11:10, pages 761-808.
Crossref
Crossref
Qin Fan, Wenhao Lv, Yuexin Xu, Yuan Dong, Zhiqiang Xiang & Junjie Wang. (2020) Selective Vascular Endothelial Growth Factor Receptor Inhibitors Provide Limited Benefits for Metastatic Colorectal Cancer: A Meta-Analysis. Current Pharmaceutical Design 26:26, pages 3171-3186.
Crossref
Crossref
Marwa A. Hasby Saad & Noha El‐Anwar. (2020) Bevacizumab as a potential anti‐angiogenic therapy in schistosomiasis: A double‐edged, but adjustable weapon. Parasite Immunology.
Crossref
Crossref
Paweł Kiczmer, Alicja Prawdzic Seńkowska, Agnieszka Kula, Miriam Dawidowicz, Joanna Katarzyna Strzelczyk, Ewa Nowakowska Zajdel, Katarzyna Walkiewicz, Dariusz Waniczek, Zofia Ostrowska & Elżbieta Świętochowska. (2020) Assessment of CMKLR1 level in colorectal cancer and its correlation with angiogenic markers. Experimental and Molecular Pathology 113, pages 104377.
Crossref
Crossref
Johanna C. Bendell, Tamara Sauri, Antonio Cubillo Gracián, Rafael Alvarez, Carlos López-López, Pilar García-Alfonso, Maen Hussein, Maria-Luisa Limon Miron, Andrés Cervantes, Clara Montagut, Cristina Santos Vivas, Alberto Bessudo, Patricia Plezia, Veerle Moons, Johannes Andel, Jaafar Bennouna, Andre van der Westhuizen, Leslie Samuel, Simona Rossomanno, Christophe Boetsch, Angelika Lahr, Izolda Franjkovic, Florian Heil, Katharina Lechner, Oliver Krieter & Herbert Hurwitz. (2020) The McCAVE Trial: Vanucizumab plus mFOLFOX-6 Versus Bevacizumab plus mFOLFOX-6 in Patients with Previously Untreated Metastatic Colorectal Carcinoma (mCRC). The Oncologist 25:3, pages e451-e459.
Crossref
Crossref
Justine Fritz, Olivier Lefebvre, Aurore Fernandez, Jordane Schmidt & Dominique Bagnard. (2020) Prediction of Drug Efficacy in Colon Cancer Preclinical Models Using a Novel Ranking Method of Gene Expression. Cancers 12:1, pages 149.
Crossref
Crossref
Wolf H. Fridman, Ian Miller, Catherine Sautès-Fridman & Annette T. Byrne. (2020) Therapeutic Targeting of the Colorectal Tumor Stroma. Gastroenterology 158:2, pages 303-321.
Crossref
Crossref
Shelize Khakoo, Ian Chau, Ian Pedley, Richard Ellis, Will Steward, Mark Harrison, Shobhit Baijal, Saad Tahir, Paul Ross, Sherif Raouf, Agnes Ograbek & David Cunningham. (2019) ACORN: Observational Study of Bevacizumab in Combination With First-Line Chemotherapy for Treatment of Metastatic Colorectal Cancer in the UK. Clinical Colorectal Cancer 18:4, pages 280-291.e5.
Crossref
Crossref
Winnie Fong & Kenneth K. W. To. (2019) Drug repurposing to overcome resistance to various therapies for colorectal cancer. Cellular and Molecular Life Sciences 76:17, pages 3383-3406.
Crossref
Crossref
Alessandro Ottaiano, Monica Capozzi, Salvatore Tafuto, Alfonso De Stefano, Chiara De Divitiis, Carmela Romano, Antonio Avallone & Guglielmo Nasti. (2019) Folfiri-Aflibercept vs. Folfiri-Bevacizumab as Second Line Treatment of RAS Mutated Metastatic Colorectal Cancer in Real Practice. Frontiers in Oncology 9.
Crossref
Crossref
Worapong Khaodee, Suruk Udomsom, Phraepakaporn Kunnaja & Ratchada Cressey. (2019) Knockout of glucosidase II beta subunit inhibits growth and metastatic potential of lung cancer cells by inhibiting receptor tyrosine kinase activities. Scientific Reports 9:1.
Crossref
Crossref
Bao T. Le, Prithi Raguraman, Tamer R. Kosbar, Susan Fletcher, Steve D. Wilton & Rakesh N. Veedu. (2019) Antisense Oligonucleotides Targeting Angiogenic Factors as Potential Cancer Therapeutics. Molecular Therapy - Nucleic Acids 14, pages 142-157.
Crossref
Crossref
Thomas Zander, Valentin Goede & Michael Hallek. 2019. Tumor Angiogenesis. Tumor Angiogenesis
379
394
.
Dongdong Sun, Feng Zhang, Jie Qian, Weixing Shen, Huisen Fan, Jiani Tan, Liu Li, Changliang Xu, Ye Yang & Haibo Cheng. (2018) 4′-hydroxywogonin inhibits colorectal cancer angiogenesis by disrupting PI3K/AKT signaling. Chemico-Biological Interactions 296, pages 26-33.
Crossref
Crossref
Jinil Kim, Sang Hyun Choi, Su Jung Ham, Young Chul Cho, Seul-I Lee, Jeeheon Kang, Dong-Cheol Woo, Weon Sub Lee, Jin-San Yoo, Kyung Won Kim & Yoonseok Choi. (2018) Evaluation of drug mechanism and efficacy of a novel anti-angiogenic agent, TTAC-0001, using multi-modality bioimaging in a mouse breast cancer orthotopic model. PLOS ONE 13:1, pages e0187063.
Crossref
Crossref
Maureen Van de Velde, Melissa García-Caballero, Tania Durré, Frédéric Kridelka & Agnès Noël. 2018. Proteases and Cancer. Proteases and Cancer
223
233
.
Isabel Corraliza-Gorjón, Beatriz Somovilla-Crespo, Silvia Santamaria, Jose A. Garcia-Sanz & Leonor Kremer. (2017) New Strategies Using Antibody Combinations to Increase Cancer Treatment Effectiveness. Frontiers in Immunology 8.
Crossref
Crossref
Sufeng Zhou, Feng Shao, Zhaoqiang Xu, Lu Wang, Ke Jin, Lijun Xie, Juan Chen, Yun Liu, Hongwen Zhang & Ning Ou. (2017) A phase I study to investigate the metabolism, excretion, and pharmacokinetics of [14C]fruquintinib, a novel oral selective VEGFR inhibitor, in healthy Chinese male volunteers. Cancer Chemotherapy and Pharmacology 80:3, pages 563-573.
Crossref
Crossref
Li-Hong Wang, Hsiao-Chi Tsai, Yu-Che Cheng, Chih-Yang Lin, Yuan-Li Huang, Chun-Hao Tsai, Guo-Hong Xu, Shih-Wei Wang, Yi-Chin Fong & Chih-Hsin Tang. (2017) CTGF promotes osteosarcoma angiogenesis by regulating miR-543/angiopoietin 2 signaling. Cancer Letters 391, pages 28-37.
Crossref
Crossref
Thomas Zander, Valentin Goede & Michael Hallek. 2017. Tumor Angiogenesis. Tumor Angiogenesis
1
16
.
Masatake Tanaka & Yasuko Iwakiri. (2016) The Hepatic Lymphatic Vascular System: Structure, Function, Markers, and Lymphangiogenesis. Cellular and Molecular Gastroenterology and Hepatology 2:6, pages 733-749.
Crossref
Crossref
Yasuko Iwakiri. (2016) The lymphatic system: A new frontier in hepatology. Hepatology 64:3, pages 706-707.
Crossref
Crossref